Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe

Source
Rheumatology - ISSN 1462-0324-60:1 (2021) p. 113-124
Author(s)
    Xenofon Baraliakos, Torsten Witte, Luc S. De Clerck, Bruno Frediani, Eduardo Collantes-Estevez, Gkikas Katsifis, Brenda VanLunen, Elisabeth Kleine, Bengt Hoepken, Lars Bauer, Nicola Goodson